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ABSTRACT. A 5-month old Caucasian dog was presented with a 20-day history of abdominal distention along with inap-
petance, depression and vomiting of 24-hour duration. Physical examination findings included depression, ascites, mild inspira-
tory dyspnea and dehydration. Clinicopathological evaluation revealed hyperammonemia, hypoalbuminemia, hyperbilirubinemia, 
hypoglycemia and hyponatremia. Μicrohepatia and free abdominal fluid was detected with abdominal ultrasonography. During 
exploratory laparotomy, multiple acquired portosystemic collateral vessels were found, indicative of portal hypertension, along 
with a small liver of normal color and texture. Liver histopathology included features consistent with liver hypoperfusion. These 
findings supported the diagnosis of primary portal vein hypoplasia with portal hypertension. The animal recovered uneventfully 
postoperatively and was discharged with diuretics, hepatoprotectants and a low-protein diet and remains healthy two years after 
diagnosis. This case underscores that a favorable prognosis may be anticipated in cases of primary portal vein hypoplasia with 
portal hypertension, thus, justifying the long-term conservative management instead of considering euthanasia.
Keywords: ascites, dog, portal hypertension, portal vein hypoplasia.
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INTRODUCTION
Congenital hepatic vascular anomalies described in the dog include primary portal vein hypopla-
sia (PPVH), hepatic arteriovenous malformations, 
portal vein atresia and congenital portosystemic 
shunts (CPSS) (berent and Tobias, 2009). based 
on the latest nomeclature proposed by the WSAVA 
Study Liver Group, PPVH is the preferred term to de-
scribe a number of conditions with clinical, clinico-
pathological, and histopathological similarities such 
as non-cirrhotic portal hypertension, hepatoportal 
fibrosis, idiopathic hepatic fibrosis, veno-occlusive 
disease, idiopathic liver disease, non-fibrosing liver 
disease and hepatic microvascular dysplasia (Cullen, 
2009). In PPVH the intrahepatic and occasionally the 
extrahepatic portal vein are abnormally small or ab-
sent, resulting in hepatic hypoperfusion and micro-
hepatia without evidence of cirrhosis. The subsequent 
resistance in hepatic blood flow can lead, although not 
invariably, to the development of portal hypertension 
and peritoneal effusion (berent and Weisse, 2010). 
The purpose of our study is to describe the clinical 
presentation, clinicopathological abnormalities, diag-
nosis and treatment of a dog with PPVH and portal 
hypertension.
CASE DESCRIPTION
A 5-month-old, intact female, Caucasian dog 
was presented with a 20-day history of abdominal 
enlargement. During the last 24 hours the animal 
had displayed inappetence, depression and vomit-
ing. Physical examination revealed mild inspiratory 
dyspnea, dehydration and abdominal distention con-
sistent with peritoneal effusion (Fig. 1). Complete 
blood count was unremarkable, while biochemical 
abnormalities included hyperammonemia, hypoalbu-
minemia, hyperbilirubinemia, hyponatremia, and 
mild hypoglycemia (Table 1). Thoracic radiogra-
phy was normal, while abdominal ultrasonography 
revealed large amounts of free abdominal fluid and 
microhepatia. No evidence of intrahepatic or extra-
hepatic vascular anomalies was detected. Peritoneal 
fluid obtained with a butterfly-assisted abdominoc-
entesis was analyzed and classified as a pure tran-
sudate based on the low total protein concentration 
(0.5 g dL-1)  and nucleated cell count (0 cells μL-1) 
on an automated analyzer. Cytologic examination of 
a buffy coat blood smear for Babesia sp. organisms 
and serology for Dirofilaria immitis antigens (dot-
ELISA Heartworm Snap test®, IDEXX) were nega-
tive.
 Since a hepatic vascular anomaly was the pri-
ΠΕΡΙΛΗΨΗ. Σκύλος φυλής Καυκάσου, ηλικίας 5 μηνών, προσκομίστηκε με ιστορικό διόγκωσης της κοιλίας διάρκειας 20 
ημερών και ανορεξίας, κατάπτωσης και εμέτων κατά το τελευταίο 24ωρο. Στην κλινική εξέταση παρατηρήθηκαν κατάπτωση, 
ασκίτης, ήπια εισπνευστική δύσπνοια και αφυδάτωση. Κατά την εργαστηριακή διερεύνηση διαπιστώθηκαν υπεραμμωνιαιμία, 
υπολευκωματιναιμία, υπερχολερυθριναιμία, υπογλυκαιμία και υπονατριαιμία. Τα ευρήματα της υπερηχοτομογραφικής διερεύ-
νησης της κοιλίας ήταν μικροηπατία και ελεύθερο περιτοναϊκό υγρό.  Στην ερευνητική λαπαροτομή διαπιστώθηκαν πολλαπλές 
επίκτητες εξωηπατικές αναστομώσεις της πυλαίας φλέβας, συμβατές με πυλαία υπέρταση, ενώ το ήπαρ ήταν μικρό σε μέγεθος 
και φυσιολογικής υφής και χρώματος. Η ιστοπαθολογική εξέταση του ήπατος ήταν συμβατή με υποαιμάτωση του οργάνου. Με 
βάση τα παραπάνω αποτελέσματα τέθηκε η διάγνωση της πρωτογενούς υποπλασίας της πυλαίας φλέβας με πυλαία υπέρταση. 
Η αγωγή που ακολουθήθηκε συμπεριλάμβανε διουρητικά, ηπατοπροστατευτικά και διατροφή χαμηλή σε πρωτεΐνες. Ο σκύλος 
παραμένει  υγιής δύο χρόνια μετά τη διάγνωση. Το περιστατικό αυτό, αναδεικνύει την καλή μακροχρόνια πρόγνωση που έχουν 
τα περιστατικά με πρωτογενή υποπλασία της πυλαίας φλέβας και πυλαία υπέρταση στο σκύλο, γεγονός που δικαιολογεί την 
συντηρητική θεραπευτική αντιμετώπιση και την αποθάρρυνση της διενέργειας ευθανασίας.
Λέξεις ευρετηρίασης: ασκίτης, πυλαία υπέρταση, σκύλος, υποπλασία πυλαίας φλέβας.
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Glaxo Smith Kline), metoclopramide (0.5 mg kg-1 
bw, every 8 hours, intravenously) (Primperan, 
Sanofi-Aventis), sucralfate (1 g 30 kg-1 bw, every 8 
hours, per os) (Peptonorm, unifarma) and furosem-
ide (2 mg kg-1 bw, every 12 hours, intravenously) 
(Lasix, Sanofi-Aventis). Abdominocentesis was per-
formed once a day for the first two days to relieve 
dyspnea, with a total volume of 3 liters of abdomi-
nal fluid being gradually removed. On the 3rd day, 
spironolactone (1 mg kg-1 bw, every 12 hours, intra-
venously) (Aldactone, Pfizer) was added to further 
mobilize the ascitic fluid. Additionally, a therapeutic 
trial with imidocarb dipropionate (3 mg kg-1 bw, 
subcutaneously) was commenced (Imizol, Schering-
Plough). The dog’s appetite and demeanor returned 
to normal on the 9th day of hospitalization.
Exploratory laparotomy was performed on the 
10th day of hospitalization after administering one 
unit of fresh cross-matched and blood-typed whole 
blood. A small liver with normal texture and multiple 
tortuous acquired portosystemic collaterals (APSC) 
located near the kidneys were seen (Fig. 2). No gross 
lesions of neoplastic or inflammatory nature were 
identified and the portal vein appeared patent and of 
presumed normal size. A liver biopsy was obtained 
mary differential, exploratory laparotomy was recom-
mended in order to visualize the hepatic vasculature, 
ligate any shunting vessel if possible and obtain liver 
biopsies. Pending the owner’s decision the dog, was 
hospitalized and given intravenous crystalloids (NS 
0.9%)  along with lactulose (3.35 g kg-1 bw, every 
12 hours, per os) (Duphalac, Solvay), ranitidine (2.5 
mg kg-1 bw, every 12 hours, intravenously) (zantac, 
Figure 1. Abdominal distention compatible with ascites in a 
young Caucasian dog with primary portal vein hypoplasia and 
portal hypertension.
Table 1. biochemical findings on admission in a dog with primary portal vein hypoplasia and portal hypertension
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and submitted for routine histopathology. The his-
topathological findings included diminished portal 
vein profiles, portal arteriolar and bile duct prolif-
eration along with portal fibrosis, consistent with a 
hepatic circulatory disorder associated with portal 
vein hypoperfusion (Fig. 3). Additional features 
included mild hepatitis with a mixed inflammatory 
cell infiltrate; multifocal capsular and patchy sub-
capsular mild perisinusoidal fibrosis with vascular 
proliferation and sinusoidal dilation and congestion. 
However these latter findings were not considered 
to be supportive of an underlying primary hepatic 
disease with advanced fibrosis as the cause of portal 
hupertension. based on the clinical, clinicopatho-
logical and histopathological findings, a diagnosis of 
PPVH with portal hypertension was reached.
Following surgery the dog was discharged on 
lactulose (3.35 g kg-1 bw, every 12 hours, per os) 
(Duphalac, Solvay), spironolactone (1 mg kg-1 bw, 
every 12 hours, per os) (Aldactone, Pfizer), furosem-
ide (1 mg kg-1 bw, every 12 hours, per os) (Lasix, 
Sanofi-Aventis), S-adenyl-methionine (20 mg kg-1 
bw, every 24 hours, per os) (Denosyl, Nutramax), 
ursodeoxicholic acid (15 mg kg-1 bw, every 24 hours, 
per os) (ursofalk, Galenika) and famotidine (0.5 mg 
kg-1 bw, every 24 hours, per os) (Peptan, Vianex), 
along with a protein and sodium restricted diet. One 
week later the dog was bright and alert with a nor-
mal appetite. A small amount of abdominal fluid 
was detected on physical examination. upon reex-
amination, seven months after surgery, no clinical 
abnormalities were noticed other than a degree of 
stunted growth (Fig. 4), while complete blood count 
and blood biochemisrty where within normal limits 
with the exception of a mildly elevated ammonia 
concentration (104 μg dL-1, reference intervals, 16-75 
μg dL-1). The owners were satisfied with their dog’s 
quality of life.
DISCUSSION
PPVH with portal hypertension has been 
described in a wide variety of breeds, with 
Dobermans being overrepresented. Age of presenta-
tion ranges from 3 months to 8 years, with the major-
ity of dogs being less than 4 year-old at the time of 
diagnosis, similar to the present case (de Marco et 
al., 1998; bunch et al., 2001). Abdominal distention, 
intermittent gastrointestinal signs, polydipsia, small 
stature and central nervous system signs related to 
Figure 2. Multiple extrahepatic acquired portosystemic collater-
als (arrows) causal to the left kidney (asterisk).
Figure 3. Portal region with multiple arteriolar profiles and 
increased portal fibrous connective tissue. The portal vein is not 
apparent. There is minimal to mild portal and periportal popula-
tion of lymphocytes and fewer neutrophils (Hematoxylin-Eosin, 
bar: 50μm) 
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hepatic vascular anomalies, thus, they cannot be used 
to differentiate them (berent and Tobias, 2009). 
Ascitic fluid in portal hypertension is classi-
fied either as a pure or a modified transudate. In the 
absence of severe hypoalbuminemia, protein concen-
tration can be helpful in determining the anatomic 
location of portal hypertension (Johnson, 1987). 
Prehepatic and presinusoidal causes of increased 
portal pressures, like PPVH, invariably lead to the 
development of a low-protein fluid accumulation 
(pure transudate), as was the case in the present 
report. In contrast, ascitic fluid in postsinusoidal 
and posthepatic diseases has high protein concentra-
tion (modified transudate) (buob et al., 2011). The 
protein concentration of ascitic fluid associated with 
sinusoidal causes of portal hypertension (e.g., liver 
cirrhosis) is unpredictable, because, even though a 
high protein ascitic fluid is anticipated, hypoalbu-
minemia and sinusoid capilarization may result in a 
pure transudate formation (Johnson, 1987). 
The suspicion of a liver vascular anomaly in 
the current case was based on the increased fast-
ing plasma ammonia concentration. The differential 
diagnosis of increased fasting plasma ammonia con-
centration further include loss of >70% of functional 
liver parenchyma, urea cycle enzyme deficiencies 
(Szatmary et al., 2004) and physiologic hyperammo-
niema (Irish Wolfhounds) (Meyer et al., 1996). The 
overall sensitivity and specificity of fasting plasma 
ammonia for the detection of hepatic vascular anom-
alies range from 68%-100% and 86-89%, respec-
tively. (Meyer, 1986; Walker et al., 2001; Gerritzen-
bruning et al., 2006; ruland et al., 2010). Even 
though, measurement of pre- and postprandial bile 
acids seems to be a more sensitive indicator of liver 
vascular anomalies, there is no apparent benefit in 
performing both when one value is abnormal (Meyer 
et al., 1986; Winkler et al., 2003). In the current case, 
since there was marked hyperammonemia measure-
ment of bile acids was not deemed necessary.
Abdominal ultrasonography findings in animals 
hepatic encephalopathy are common historical and 
clinical manifestations in dogs with PPVH and portal 
hypertension (van den Ingh et al., 1995; de Marco et 
al., 1998; bunch et al., 2001). In the absence of overt 
neurologic signs (eg cortical blindness, seizures, 
coma) the diagnosis of hepatic encephalopathy can 
be elusive. The presence of depression in conjunction 
with the persistent hyperammonemia is an early indi-
cator of hepatic encephalopathy (Adam et al., 2012). 
The majority of the typical manifestations of the dis-
ease were witnessed in the present case.
Clinicopathological abnormalities in dogs 
with PPVH and portal hypertension are the result 
of hepatic hypoperfusion, increased portal pressure 
and failure to metabolize ammonia (buob et al., 
2011). Typically, hypoalbuminemia, moderate to 
severe increases in liver enzyme activities, hyperbi-
lirubinemia, hyponatremia, increased fasting serum 
ammonia and total serum bile acid concentrations 
are seen. Less commonly, low buN concentration 
and hypoglycemia are documented (van den Ingh et 
al., 1995; de Marco et al., 1998; bunch et al., 2001; 
James et al., 2008). Several of the expected biochem-
ical alterations were seen in this case. These find-
ings, however, are nonspecific and may be seen in all 
Figure 4. The same dog as in figure 1, seven months after diag-
nosis displaying retarded growth.
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riovenous malformations and portal vein thrombosis 
(bunch et al., 2001). The importance of acquiring 
hepatic biopsies in such cases relies in document-
ing a pattern of hepatic hypoperfusion and most 
importantly, excluding severe diffuse hepatobilliary 
disease as the cause of portal hypertension (van den 
Ingh et al., 1995).
Diagnosis of PPVH in the current case was 
based on the clinical manifestations suggestive of 
portal hypertension along with histopathological 
findings consistent with hepatic hypoperfusion. Even 
though portal pressures were not directly measured, 
the diagnosis of portal hypertension can be reliably 
based on the presence of ascites (in the absence of 
severe hypoalbuminemia) and numerous APSC (van 
den Ingh et al., 1995; rohuizen, 2009). Other differ-
entials included portal vein obstruction and hepatic 
artiriovenous malformations. Portal vein obstruc-
tion was excluded based on the absence of visible 
thrombi, local neoplastic and inflammatory condi-
tions during laparotomy and lack of predisposing 
factors (abdominal surgery, steroid administration) 
or clinicopathological evidence of concurrent disease 
that can lead to a hypercoagulable state (pancreatits, 
peritonitis, protein loosing nephropathy and enter-
opathy) (Winkler and bruce, 1993). Hepatic arterio-
venous malformations were excluded on the basis of 
absent compatible ultrasonographicc and macroscop-
ic findings during laparotomy (Chanoit et al., 2007). 
Although advanced imaging was not undertaken, 
CPSS was excluded since they are not accompanied 
by portal hypertension (Winkler et al., 2003).
Therapeutic recommendations in PPVH aim to 
alleviate symptoms and prevent lethal complications 
of sustained chronic portal hypertension. To this 
end, treatment in the present case targeted to mobi-
lize the ascitic fluid, reduce ammonia concentration, 
ameliorate gastrointestinal signs, and prevent fur-
ther liver damage. The use of a protein- and sodium 
restricted diet is sufficient to control ascites in most 
of the cases (bunch et al., 2001). When diuretics are 
with PPVH include alterations in liver size and echo-
genicity, abdominal effusion, APSC, renomegaly, 
splenomegaly, enlarged portal vein and caudal vena 
cava (bunch et al., 2001; de Marco et al., 1996). In 
our case, besides abdominal effusion and microhepa-
tia, ultrasonography was unremarkable. regarding 
the detection of CPSS and APCS the sensitivity and 
specificity of abdominal ultrasonography ranges 
from 80.5% to 98% and 66.7% to 98% respective-
ly but it is considered a very operator dependent 
examination (Lamb, 1996). Even though it is a very 
important tool, not only in detecting liver vascular 
anomalies but also for investigating other causes of 
abdominal distention in the dog, it should not be used 
alone to rule out the presence of CPSS and APCS 
(Winkler et al., 2003).
Gross pathological findings during exploratory 
laparotomy include small liver with various colora-
tion and texture, portosystemic collateral vessels and 
free abdominal fluid. The extrahepatic portion of the 
portal vein is apparently normal in the majority of 
cases, similar to the current case, and no correlation 
exists between the presence or not of gross hypopla-
sia and the histological pattern within the portal area 
(van den Ingh et al., 1982; rutgers et al., 1990; Hunt 
et al., 1993; van den Ingh et al., 1995; de Marco et 
al., 1998). APSC develop secondary to chronic por-
tal hypertension of pre- or intrahepatic, but not of 
posthepatic origin, and they are usually detected in 
the omentum just caudal to the left kidney as was 
documented in the present case (Fig. 3) (rothuizen, 
2009).
The histopathological features observed in 
PPVH reflect stereotypical changes that arise as 
a consequence of hepatic hypoperfusion and may 
include loss or diminution of portal vein profiles, 
increased arterioral profiles in the portal tract and 
hepatocellular atrophy with varying degrees of fibro-
sis within and between the portal tracts (buob et al., 
2011). The histopathological pattern in PPVH over-
laps considerably with that of CPSS, hepatic arte-
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needed, the aldosterone antagonist spironolactone is 
preferred. because fluid mobilization is slow with 
spironolactone, low dose furosemide can be added 
to enhance initial natriuresis (buob et al., 2011). 
Abdominocentesis is recommended when respiratory 
compromise develops due to abdominal distention. 
Fluid removal must be gradual as in the present case, 
since circulatory collapse and renal function deterio-
ration may occur (rothuizen, 2009). The most com-
mon and potentially lethal consequence of chronic 
portal hypertension is the development of gastroduo-
denal ulcers (buob et al., 2009). Thus, the continuous 
use of antiulcer medication, such as histamine type-2 
receptor antagonists, is essential for long term man-
agement (bunch et al., 2001).
Antifibrotic therapy (colchicine, glucocorticoids) 
has been suggested by some authors since there is 
evidence for a gradually increasing fibrosis in animals 
subject to serial liver biopsies (rutgers et al., 1990; 
1993). However, there are currently no evidence-
based suggestions to support its efficacy in PPVH. 
Nonetheless, colchicine may be considered when 
significant fibrosis exists in liver histopathology at the 
time of diagnosis (bunch et al., 2001).
The prognosis of PPVH with portal hyperten-
sion depends upon the severity of clinical signs and 
the response to initial treatment but it is generally 
considered favourable (buob et al., 2011). In a retro-
spective study of PPVH and portal hypertension for 
19 cases where long term follow up was available, 
13 remained asymptomatic for a period ranging from 
5 months to 9 years (median 2.9 years) after diagno-
sis. In the same study a number of dogs were eutha-
nized before final diagnosis was reached because of 
a presumed poor prognosis (bunch et al., 2001). In 
the present case clinical signs related to PPVH were 
adequately controled following medical management 
for 2 years.
CONCLUDING REMARKS
PPVH with portal hypertension, although an 
uncommon vascular anomaly in the dog, must be 
considered in young dogs presenting with ascites. 
Symptomatic treatment is adequate for sufficient con-
trol of the symptoms in a long term basis. Due to the 
many similarities of PPVH with other life threatening 
liver diseases, liver histopathology is essential before 
establishing a prognosis. Owners, therefore, should 
be discouraged to choose euthanasia after reaching a 
diagnosis since PPVH carries a favorable prognosis 
(bunch et al., 2001). 
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